000			01692 a2200457 4500
005			20250517014441.0
264		0	_c20150924
008			201509s 0 0 eng d
022			_a1536-4798
024	7		_a10.1097/ICO.0000000000000336 _2doi
040			_aNLM _beng _cNLM
100	1		_aPark, Jin-Heung
245	0	0	_aComparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits. _h[electronic resource]
260			_bCornea _cApr 2015
300			_a449-55 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdministration, Topical
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aChemokine CCL2 _xgenetics
650	0	4	_aConjunctiva _xdrug effects
650	0	4	_aCorneal Neovascularization _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInjections, Intraocular
650	0	4	_aInterferon-gamma _xgenetics
650	0	4	_aInterleukin-1beta _xgenetics
650	0	4	_aOphthalmic Solutions
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRabbits
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aTacrolimus _xtherapeutic use
650	0	4	_aTumor Necrosis Factor-alpha _xgenetics
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
700	1		_aJoo, Choun-Ki
700	1		_aChung, Sung Kun
773	0		_tCornea _gvol. 34 _gno. 4 _gp. 449-55
856	4	0	_uhttps://doi.org/10.1097/ICO.0000000000000336 _zAvailable from publisher's website
999			_c24594364 _d24594364